<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1365</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Supplies of drugs produced in the EEU to Russia</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bespalov</surname><given-names>Nikolay</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">RNC Pharma</aff><pub-date date-type="epub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><issue>13S</issue><fpage>169</fpage><lpage>173</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>The economic integration processes in the post-Soviet space can only be welcomed. However, the formation of the Customs Union led to the abolition of customs control on the actual borders of the countries participating in the EEU, and thus deprived the pharmaceutical market of publicly available statistics on the transfer of drugs between our countries. Meanwhile, the turnover in this direction is quite high: only in 2017, the drugs produced in the EEU countries that were imported to Russia totaled to about RUB 8.4 bil. (at wholesale prices), moreover, the cash volume of such supplies shows a fairly confident positive dynamics.</abstract><kwd-group xml:lang="en"><kwd>RNC Pharma</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ЛП</kwd><kwd>ЕАЭС</kwd></kwd-group></article-meta></front><body></body><back/></article>
